Johnson & Johnson Pharmaceutical Research

Pharmaceutical research organisation of Johnson & Johnson, once Johnson & Johnson Pharmaceutical Research and Development, then Janssen Research and Development and since 2023 part of Johnson & Johnson Innovative Medicine, with sites in New Jersey, Pennsylvania, California and Belgium. Runs discovery research, translational science, clinical development, biostatistics, regulatory affairs and medical affairs for medicines in oncology, immunology, neuroscience, infectious diseases and vaccines, cardiovascular and metabolic disease and pulmonary hypertension.